Expression and activity of the calcitonin receptor family in a sample of primary human high-grade gliomas

Glioblastoma (GBM) is the most common and aggressive type of primary brain cancer. With median survival of less than 15  months, identification and validation of new GBM therapeutic targets is of critical impor...

Source: BMC Cancer - February 18, 2019 Category: Cancer & Oncology Authors: Anna Ostrovskaya, Caroline Hick, Dana S. Hutchinson, Brett W. Stringer, Peter J. Wookey, Denise Wootten, Patrick M. Sexton and Sebastian G. B. Furness Tags: Research article Source Type: research